Dengue vaccines: state of the art

被引:40
|
作者
Swaminathan, Sathyamangalam [1 ]
Batra, Gaurav [1 ]
Khanna, Navin [1 ]
机构
[1] Int Ctr Genet Engn & Biotechnol, Recombinant Gene Prod Grp, New Delhi 110067, India
关键词
chimeric vaccines; dengue vaccines; envelope domain III; gene shuffling; live attenuated vaccines; RepliVax; viral interference; TYPE-2; VIRUS; 4; SEROTYPES; NEUTRALIZING ANTIBODIES; HEMORRHAGIC-FEVER; NONHUMAN-PRIMATES; NONCODING REGION; RHESUS-MONKEYS; DOMAIN III; LIVE; IMMUNOGENICITY;
D O I
10.1517/13543771003767476
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Importance of the field: Dengue is a significant public health problem transcending geographical boundaries to place nearly 50% of the global population at risk. A vaccine to prevent dengue is an unmet need that should be addressed urgently. Areas covered in the review: A brief introduction to dengue and a detailed review of the classical and modern approaches being undertaken currently to develop dengue vaccines described in recent patent literature, highlighting the inherent hurdles and challenges. What the reader will gain: An understanding of the approaches being deployed to develop multiple viral and non-viral vaccine candidates and an appreciation of the complexity of developing dengue vaccines. Take home message: Live viral vaccines, which have advanced to clinical trials, have revealed new challenges, emphasizing the need to pursue non-viral alternatives simultaneously.
引用
收藏
页码:819 / 835
页数:17
相关论文
共 50 条
  • [21] Dengue infection and advances in dengue vaccines for children
    Halstead, Scott B.
    Dans, Leonila F.
    LANCET CHILD & ADOLESCENT HEALTH, 2019, 3 (10): : 734 - 741
  • [22] State of the art in developing allergen vaccines in Cuba:: prospects of novel adjuvanted vaccines
    Labrada, A
    Facenda, E
    Castro, RL
    Fernández, B
    Uyema, K
    Sewer, M
    Aranda, RE
    Más, A
    Navarro, B
    Jorge, O
    Novoa, I
    Díaz, J
    Bourg, V
    VACCINE, 2006, 24 : S36 - S37
  • [23] Pertussis Vaccines: State-of-the-Art and Future Trends
    Tefon, Burcu E.
    Ozcengiz, Erkan
    Ozcengiz, Gulay
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (20) : 2581 - 2596
  • [24] HIV-1 prophylactic vaccines: state of the art
    Lelievre, Jean-Daniel
    Levy, Yves
    JOURNAL OF VIRUS ERADICATION, 2016, 2 (01) : 5 - 11
  • [25] First generation prophylactic HPV vaccines: the state of the art
    Fruscalzo, A.
    Londero, A. P.
    Bertozzi, S.
    Lelle, R. J.
    MINERVA MEDICA, 2015, 106 (05) : 275 - 285
  • [26] Ten years of HPV vaccines: State of art and controversies
    Angioli, Roberto
    Lopez, Salvatore
    Aloisi, Alessia
    Terranova, Corrado
    De Cicco, Carlo
    Scaletta, Giuseppe
    Capriglione, Stella
    Miranda, Andrea
    Luvero, Daniela
    Ricciardi, Roberto
    Montera, Roberto
    Plotti, Francesco
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 102 : 65 - 72
  • [27] Classical swine fever vaccines-State-of-the-art
    Blome, Sandra
    Moss, Claudia
    Reimann, Ilona
    Koenig, Patricia
    Beer, Martin
    VETERINARY MICROBIOLOGY, 2017, 206 : 10 - 20
  • [28] State of the art of HCV vaccines in the era of new antivirals
    Hynicka, L. M.
    DRUGS OF THE FUTURE, 2017, 42 (03) : 157 - 160
  • [29] The state of art patent search with an example of human vaccines
    Wang, Shyh-Jen
    HUMAN VACCINES, 2011, 7 (02): : 265 - 268
  • [30] Cancer Vaccines: State of the Art of the Computational Modeling Approaches
    Pappalardo, Francesco
    Chiacchio, Ferdinando
    Motta, Santo
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013